Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (989)	7/8/1998 11:55:00 PM
From: Ed Ajootian	Read Replies (1) \| Respond to of 10280

Bruce, These bonds were issued in a private placement and are not tradeable here in the US. Publicly traded convertible bonds that are in the money usually trade at a slight premium to their intrinsic (ie converted) value, I believe. The bondholders probably won't start shorting against the box until the stock appreciates another 50% or so from here, at least at this early stage. They have 3 years before SEPR even has the power to force conversion, and a lot can happen in that period. Hopefully they will cut a deal with Eli Lilly pretty soon and blast the hell out of this roadblock.